Evaluation of lung recovery after static administration of three different perfluorocarbons in pigs

被引:9
作者
Chenoune, Mourad [1 ,2 ,3 ]
De Rochefort, Ludovic [4 ]
Bruneval, Patrick [5 ]
Lidouren, Fanny [1 ,2 ,3 ]
Kohlhauer, Matthias [1 ,2 ,3 ]
Seemann, Aurelien [1 ,2 ,3 ]
Ghaleh, Bijan [1 ,2 ,3 ]
Korn, Matthias [4 ]
Dubuisson, Rose-Marie [4 ]
Ben Yahmed, Anis [4 ]
Maitre, Xavier [4 ]
Isabey, Daniel [1 ,2 ]
Ricard, Jean-Damien [6 ,7 ,8 ]
Kerber, Richard E. [9 ]
Darrasse, Luc [4 ]
Berdeaux, Alain [1 ,2 ,3 ]
Tissier, Renaud [1 ,2 ,3 ,10 ]
机构
[1] INSERM, U955, Equipe 3, F-94010 Creteil, France
[2] Univ Paris Est, UPEC, UMR S955, F-94010 Creteil, France
[3] Univ Paris Est, Ecole Natl Vet, Maisons Alfort, France
[4] Univ Paris Sud, CNRS, IR4M, UMR8081, Orsay, France
[5] INSERM, U970, F-75015 Paris, France
[6] Univ Paris 07, INSERM, IAME, UMR 1137, F-75018 Paris, France
[7] Univ Paris Diderot, IAME, UMR 1137, F-75018 Paris, France
[8] Hop Louis Mourier, AP HP, Serv Reanimat Med Chirurg, F-92700 Colombes, France
[9] Univ Iowa Hosp & Clin, Dept Internal Med, Div Cardiovasc Med, Iowa City, IA 52242 USA
[10] Ecole Natl Vet, INSERM, U955, F-94704 Maisons Alfort, France
关键词
Perfluorocarbon; Liquid ventilation; Macrophage; Swine; PARTIAL LIQUID VENTILATION; RESPIRATORY-DISTRESS-SYNDROME; CARDIAC-ARREST; ADULT PATIENTS; PERFLUOROCHEMICAL LIQUID; SPONTANEOUS CIRCULATION; PERFLUBRON; RABBITS; RATS; ELIMINATION;
D O I
10.1186/2050-6511-15-53
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The respiratory properties of perfluorocarbons (PFC) have been widely studied for liquid ventilation in humans and animals. Several PFC were tested but their tolerance may depend on the species. Here, the effects of a single administration of liquid PFC into pig lungs were assessed and compared. Three different PFC having distinct evaporative and spreading coefficient properties were evaluated (Perfluorooctyl bromide [PFOB], perfluorodecalin [PFD] and perfluoro-N-octane [PFOC]). Methods: Pigs were anesthetized and submitted to mechanical ventilation. They randomly received an intra-tracheal administration of 15 ml/kg of either PFOB, PFD or PFOC with 12 h of mechanical ventilation before awakening and weaning from ventilation. A Control group was submitted to mechanical ventilation with no PFC administration. All animals were followed during 4 days after the initial PFC administration to investigate gas exchanges and clinical recovery. They were ultimately euthanized for histological analyses and assessment of PFC residual concentrations within the lungs using dual nuclei fluorine and hydrogen Magnetic Resonance Imaging (MRI). Sixteen animals were included (4/group). Results: In the PFD group, animals tended to be hypoxemic after awakening. In PFOB and PFOC groups, blood gases were not significantly different from the Control group after awakening. The poor tolerance of PFD was likely related to a large amount of residual PFC, as observed using MRI in all lung samples (approximate to 10% of lung volume). This percentage was lower in the PFOB group (approximate to 1%) but remained significantly greater than in the Control group. In the PFOC group, the percentage of residual PFC was not significantly different from that of the Control group (approximate to 0.1%). Histologically, the most striking feature was an alveolar infiltration with foam macrophages, especially in the groups treated by PFD or PFOB. Conclusions: Of the three tested perfluorocarbons, PFOC offered the best tolerance in terms of lung function, gas exchanges and residuum in the lung. PFOC was rapidly cleared from the lungs and virtually disappeared after 4 days whereas PFOB persisted at significant levels and led to foam macrophage infiltration. PFOC could be relevant for short term total liquid ventilation with a rapid weaning.
引用
收藏
页数:9
相关论文
共 37 条
[1]   Total liquid ventilation efficacy in an ovine model of severe meconium aspiration syndrome [J].
Avoine, Olivier ;
Bosse, Dominick ;
Beaudry, Benoit ;
Beaulieu, Alexandre ;
Albadine, Roula ;
Praud, Jean-Paul ;
Robert, Raymond ;
Micheau, Philippe ;
Walti, Herve .
CRITICAL CARE MEDICINE, 2011, 39 (05) :1097-1103
[2]   Ultrafast and Whole-Body Cooling With Total Liquid Ventilation Induces Favorable Neurological and Cardiac Outcomes After Cardiac Arrest in Rabbits [J].
Chenoune, M. ;
Lidouren, F. ;
Adam, C. ;
Pons, S. ;
Darbera, L. ;
Bruneval, P. ;
Ghaleh, B. ;
Zini, R. ;
Dubois-Rande, J. -L. ;
Carli, P. ;
Vivien, B. ;
Ricard, J. -D. ;
Berdeaux, A. ;
Tissier, R. .
CIRCULATION, 2011, 124 (08) :901-U112
[3]   Rapid cooling of the heart with total liquid ventilation prevents transmural myocardial infarction following prolonged ischemia in rabbits [J].
Chenoune, Mourad ;
Lidouren, Fanny ;
Ghaleh, Bijan ;
Couvreur, Nicolas ;
Dubois-Rande, Jean-Luc ;
Berdeaux, Alain ;
Tissier, Renaud .
RESUSCITATION, 2010, 81 (03) :359-362
[4]   SURVIVAL OF MAMMALS BREATHING ORGANIC LIQUIDS EQUILIBRATED WITH OXYGEN AT ATMOSPHERIC PRESSURE [J].
CLARK, LC ;
GOLLAN, F .
SCIENCE, 1966, 152 (3730) :1755-&
[5]   Hypothermic Liquid Ventilation Prevents Early Hemodynamic Dysfunction and Cardiovascular Mortality After Coronary Artery Occlusion Complicated by Cardiac Arrest in Rabbits [J].
Darbera, Lys ;
Chenoune, Mourad ;
Lidouren, Fanny ;
Kohlhauer, Matthias ;
Adam, Clovis ;
Bruneval, Patrick ;
Ghaleh, Bijan ;
Dubois-Rande, Jean-Luc ;
Carli, Pierre ;
Vivien, Benoit ;
Ricard, Jean-Damien ;
Berdeaux, Alain ;
Tissier, Renaud .
CRITICAL CARE MEDICINE, 2013, 41 (12) :E457-E465
[6]   PERFLUOROCHEMICAL LIQUID VENTILATION - FROM THE ANIMAL LABORATORY TO THE INTENSIVE-CARE UNIT [J].
DEGRAEUWE, PLJ ;
VOS, GD ;
BLANCO, CE .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1995, 18 (10) :674-683
[7]   Thermodynamic properties of perfluoro-n-octane [J].
Dias, AMA ;
Caço, AI ;
Coutinho, JAP ;
Santos, LMNBF ;
Piñeiro, MM ;
Vega, LF ;
Gomes, MFC ;
Marrucho, IM .
FLUID PHASE EQUILIBRIA, 2004, 225 (1-2) :39-47
[8]   Liquid Perfluorocarbons as Contrast Agents for Ultrasonography and 19F-MRI [J].
Diaz-Lopez, Raquel ;
Tsapis, Nicolas ;
Fattal, Elias .
PHARMACEUTICAL RESEARCH, 2010, 27 (01) :1-16
[9]  
Faithfull N, 2001, US Patent, Patent No. [6,289,892, 6289892]
[10]   PHARMACOKINETICS AND SIDE-EFFECTS OF PERFLUOROCARBON-BASED BLOOD SUBSTITUTES [J].
FLAIM, SF .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1994, 22 (04) :1043-1054